Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2011

Jun 2, 2011

31971_dirs_2011-06-02_90d710b5-63c5-49e5-ba34-05c7e9c0ebf6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-06-01

Reporting Person: ABRAHAM WILLIAM (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-06-01 Common Stock M 200 Acquired 16116 Direct
2011-06-01 Common Stock M 400 Acquired 16516 Direct
2011-06-01 Common Stock M 400 Acquired 16916 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-06-01 Rsus (restricted Stock Units) $0 M 200 Disposed 2018-06-01 Common Stock (200) Direct
2011-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2019-06-01 Common Stock (400) Direct
2011-06-01 Rsus (restricted Stock Units) $0 M 400 Disposed 2020-06-01 Common Stock (400) Direct
2011-06-01 Rsus (restricted Stock Units) $0 A 2000 Acquired 2021-06-01 Common Stock (2000) Direct
2011-06-01 Sars (Stock Appreciation Rights) $27.63 A 5000 Acquired 2021-06-01 Common Stock (5000) Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per
share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2006 Stock
Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year
after the grant date.

F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.

F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.